MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, VNDA has $488,948K in assets. $161,762K in debts. $84,851K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
239.22%
Quick Ratio
237.95%
Cash Ratio
58.45%
Debt to Asset Ratio
33.08%
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Thereafter
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Product revenue allowances
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-12-31
Cash and cash equivalents
84,851
Marketable securities
178,996
Accounts receivable, net
54,578
Inventory
1,852
Prepaid expenses and other current assets
26,985
Total current assets
347,262
Property and equipment, net
2,248
Operating lease right-of-use assets
3,923
Finance lease right-of-use assets
7,343
2026
1,463
2027
1,463
2028
1,463
2029
1,463
2030
1,463
Thereafter
6,822
Hetlioz
14,137
2026
5,544
2027
5,544
2028
5,544
2029
5,544
2030
5,544
Thereafter
65,232
PONVORY
92,952
2026
941
2027
941
2028
941
2029
941
2030
941
Thereafter
5,295
Nereus
10,000
Intangible assets, net
117,089
Deferred tax assets
0
Non-current inventory and other
11,083
Total assets
488,948
Accounts payable and accrued liabilities
68,297
Product revenue allowances
76,865
Total current liabilities
145,162
Operating lease non-current liabilities
2,991
Finance lease non-current liabilities
4,076
Other non-current liabilities
9,533
Total liabilities
161,762
Common stock, 0.001 par value 150,000,000 shares authorized 59,101,630 and 58,310,644 shares issued and outstanding at december 31, 2025 and 2024, respectively
59
Additional paid-in capital
721,264
Accumulated other comprehensive income
629
Accumulated deficit
-394,766
Total stockholders equity
327,186
Total liabilities and stockholders equity
488,948
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Thereafter$5,295K 2030$941K 2029$941K 2028$941K 2027$941K 2026$941K Thereafter$65,232K 2030$5,544K 2029$5,544K 2028$5,544K 2027$5,544K 2026$5,544K Thereafter$6,822K 2030$1,463K 2029$1,463K 2028$1,463K 2027$1,463K 2026$1,463K Nereus$10,000K PONVORY$92,952K Hetlioz$14,137K Prepaid expenses andother current assets$26,985K Inventory$1,852K Accounts receivable, net$54,578K Marketable securities$178,996K Cash and cashequivalents$84,851K Non-current inventory andother$11,083K Intangible assets, net$117,089K Finance leaseright-of-use assets$7,343K Operating leaseright-of-use assets$3,923K Property and equipment,net$2,248K Total current assets$347,262K Total assets$488,948K Total liabilities andstockholders equity$488,948K Total stockholdersequity$327,186K Total liabilities$161,762K Accumulated deficit-$394,766K Accumulated othercomprehensive income$629K Additional paid-in capital$721,264K Other non-currentliabilities$9,533K Finance leasenon-current liabilities$4,076K Operating leasenon-current liabilities$2,991K Total currentliabilities$145,162K Common stock, 0.001 parvalue 150,000,000...$59K Product revenueallowances$76,865K Accounts payable andaccrued liabilities$68,297K

Vanda Pharmaceuticals Inc. (VNDA)

Vanda Pharmaceuticals Inc. (VNDA)